Daily SPAC Update – October 28, 2024

by | Oct 28, 2024

NRAC Extension Set. INTE Extension Vote Today. VCIC and POLE Separate Trading Today. ONYX Acquisition to Liquidate on Nov 13.

 Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC DEAL & EXTENSION VOTES SET
NRAC – Northern Revival Acquisition Corp * EXTENSION VOTE SET: Nov 04, 2024 * trust $11.43

EXTENSION VOTES
INTE – INTEGRAL ACQUISITION CORP 1 * vote October 28, 2024 -> extend to November 5, 2025

SEPARATE WARRANTS/RIGHTS
VCIC on Oct 28
POLE on Oct 28

OTHER SPAC NEWS
ONYX – ONYX ACQUISITION CO I * Liquidation-> 2024-11-13

SPAC LIQUIDATIONS
Onyx Acquisition Co. I (ONYX)-> Liquidation on Nov 13
VISION SENSING ACQUISITION CORP. (VSAC)-> Liquidation on Oct 25
Generation Asia I Acquisition Ltd (GAQ)-> Liquidation on Oct 23

SPAC DEALS ANNOUNCED
Oct 23 | DYCQ – Dt Cloud Acquisition Corp * + Maius Pharmaceutical

YESTERDAY’S TOP SPAC GAINERS
8.82% ~ $ 10.12 | FIAC – Focus Impact Acquisition Corp. (Announced)
4.63% ~ $ 12.20 | WAVS – Western Acquisition Ventures Corp. (Announced)
3.21% ~ $ 11.88 | DECA – Denali Capital Acquisition Corp. (Announced)
2.75% ~ $ 11.20 | GATE – Marblegate Acquisition Corp. (Announced)
2.23% ~ $ 11.92 | ATEK – Athena Technology Acquisition Corp. II (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-5.51% ~ $ 11.50 | NPAB – New Providence Acquisition Corp. II (Pre-Deal)
-5.21% ~ $ 10.00 | BHAC – Focus Impact BH3 Acquisition Company (Announced)
-2.33% ~ $ 11.30 | PFTA – Portage Fintech Acquisition Corp. (Announced)
-.81% ~ $ 10.79 | SBXC – SilverBox Corp III (Pre-Deal)
-.62% ~ $ 11.31 | GODN – Golden Star Acquisition Corp (Announced)

Recent Analysis

Daily SPAC Update – August 29, 2025

Breeze DeSPACs to YD BioPharma. New Sponsor/Team at Armada Acquisition II. NMP Acquisition Separate Trading. Cantor / BSTR Release New Investor Deck.

Daily SPAC Update – August 28, 2025

Meteora’s Vikas Mittal files for Bitcoin Infrastructure Acquisition $200M IPO. DT Cloud Acquisition Extension Approved. Corner Growth Asking Shareholders to Approve Capital Increase.

Daily SPAC Update – August 27, 2025

Another Crytpo SPAC Deal as Trump + Crypto.com Team Up. M3-Brigade IPOs Another SPAC. Calm Digital IPOs for $200M. Dynamix Ticker Change Pre-DeSPAC.

Daily SPAC Update – August 26, 2025

Alchemy + Cartiga and Inflection Point III + A1R WATER Deals Announced. Southport + Angel Studios Deal Approved. New Deal Deck for Ares II and Kodiak.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.